Roger S. Newton

Roger S. Newton

Grundare på
Esperance BioVentures LLC
75 år
Health Technology
Consumer Services
Finance

Profil

Roger S.
Newton
is the founder of Esperance BioVentures LLC, founded in 1998, serving as Managing Director since 2012.
Dr. Newton was the founder of Esperion Therapeutics, Inc., founded in 1998, and served as Executive Chairman & Chief Scientific Officer from 1998 to 2016.
Dr. Newton is also the founder of Esperovax, Inc...
Current positions include Director at Celsee LLC and Director at Juventas Therapeutics, Inc. Former positions include Chairman-Atherosclerosis Drug Discovery at Warner-Lambert Co. from 1981 to 1998, Chairman at Groundwork Center for Resilient Communities, Inc., Director at Resverlogix Corp.
from 2007 to 2009, Director at Rubicon Genomics, Inc., Senior Vice President at Pfizer (St. Louis) from 2004 to 2008, and Advisory Board Member at Arboretum Ventures LLC.
Education includes undergraduate studies at Lafayette College, graduate studies at the University of Connecticut, and a doctorate from the University of California, Davis.

Aktiva positioner av Roger S. Newton

FöretagPositionStart
Grundare 2010-10-11
Direktör/Styrelseledamot 2010-06-09
Direktör/Styrelseledamot -
Grundare -

Tidigare kända positioner av Roger S. Newton

FöretagPositionSlut
RESVERLOGIX CORP. Direktör/Styrelseledamot 2009-04-01
Företagsledare/Principal 2008-01-01
Företagsledare/Principal 1998-01-01
Ordförande -
ESPERION THERAPEUTICS, INC. Grundare -
Se detaljerna i Roger S. Newtons erfarenhet

Roger S. Newtons utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

69

Första gradens relationer

14

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag14

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Finance

Health Services

Commercial Services

Health Technology

Finance

  1. Börsen
  2. Insiders
  3. Roger S. Newton